18
Feb
La medicina del futuro è bio e “su misura”
La medicina del futuro è bio e “su misura”....
AT THE
the Infinite Alpha 
The naming of Anemocyte is the result of the combination of the words “ánemos” and “cyte”. From this union, the Infinite Alpha is created, a symbol that incorporates the values of the company.
Want to know more? Watch the video
ABOUT
ANEMOCYTE
ANEMOCYTE is a Biotech Manufacturing Organization (BMO) with a strong focus on the contract development and manufacturing of Plasmids (for Viral Vector and mRNA manufacturing – High Quality and GMP) and mRNA.
OUR WEALTH OF EXPERIENCE:
of development and manufacturing experience (from R&D to GMP) in the field of Cell and Gene Therapies and Nucleic Acids.
of contract manufacturing within our group (Nine Trees Group, > 2000 employees worldwide).
WHERE WE ARE
ANEMOCYTE HEADQUARTERS
- Strategic Position – Greater Milan Area, three international airports within 50 Km.
- GMP Facility – 500 sq. m. for Advanced Theraphy production under cGMP.
- Plasmid Manufacturing Unit – 500 sq. m. of cleanrooms addressing the manufacturing needs of Plasmids from R&D to GMP.
OUR CORE BUSINESS
Plasmid Platform
Plasmid DNA development and manufacturing for viral vector and mRNA production
mRNA Platform
mRNA development and manufacturing
PLASMID
Plasmid DNA development and manufacturing for viral vector and mRNA production
APPLICATIONS
Plasmids can be used as ancillary or critical starting material for:
- AAV or lentiviral vector productions to be applied to the clinical manufacturing of gene and immuno-oncology therapies.
- mRNA manufacturing.
- clinical manufacturing of biological drugs.
MANUFACTURING Highlights
Starting from 1 mg batch size.
QUALITY Highlights
- Production and analysis are performed in ISO certified laboratories.
- Most relevant features of cGMP manufacturing are applied (e.g., traceability, document control and materials segregation).
- All the equipment for production and analysis are validated (IQ/OQ protocols).
- All the starting materials and single use components are certified as TSE-BSE free.
- Majority of analytical assays are performed in-house.
mRNA
mRNA development and manufacturing
APPLICATIONS
mRNA can be used for:
- Vaccines.
- Immuno-oncology therapies.
- Protein replacement therapies.
- Genetic diseases.
MANUFACTURING Highlights
Starting from 1 mL batch size.
QUALITY Highlights
- Production and analysis are performed in ISO certified laboratories.
- All the equipment for production and analysis are qualified.
- All the starting materials and single use components are certified as TSE-BSE free.
- Majority of analytical assays are performed in-house.
Related services
PROCESS DEVELOPMENT
Process optimization and development for different phases of Plasmids and mRNA production, and for Tech Transfer.
CRYOPRESERVATION
Storage and cryopreservation under different conditions.
STABILITY STUDIES
Long-term and accelerated studies at different temperatures.
SECONDARY PACKAGING
Anti-tampering dedicated boxes.
OUR PEOPLE
ANEMOCYTE
MEANS TALENTS
At the center of evolution, there are people who believe that change is possible. Here at Anemocyte, we support, value and inspire those with a vision of a different world. A world where science can give life new opportunities. Those who made our mission and vision theirs, find in Anemocyte the perfect environment to develop their abilities. When we find a new talent, we discover potential growth for our company project. Personal skills and the ability to dream go hand in hand with professional and business growth. What we make, is possible only thanks to our talents.
I HAVE A TALENTED SOUL FOR…
DO YOU THINK YOU HAVE WHAT IT TAKES TO BE PART OF ANEMOCYTE?
Check for our open positions
or
Apply to the Anemocyte Continuous Recruitment Process: we are always looking for interesting candidates with talented souls!
Become an ANEMOCYTER!
MEET US HERE
Meeting on
the MED
Barcelona, SPAIN
April 12-14, 2023
ASGCT
Los Angeles, USA
May 16-20, 2023
ISCT
PARIS
Paris, FR
May 31 - June 03, 2023
ABOUT US
ANEMOCYTE NEWS
18FebAnemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World 2020 in Miami
Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World...
PRESS AREA
In this press release page you can find a selection of the main articles about Anemocyte
published by newspapers and magazines, both online and on paper.
CONTACT US
Let’s make real change happen together.
Anemocyte S.r.l.
Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 | 21040 Gerenzano (VA) Italy
Ph: +39 02 99372311 | Fax: +39 02 99372313
VAT number: 12914940155
Share capital € 530.000,00 fully paid
R.E.A. 276961
Anemocyte is a proud member of
Anemocyte S.r.l.
Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 | 21040 Gerenzano (VA) Italy
Ph: +39 02 96474804 | Fax: +39 02 96474800
VAT number: 12914940155
Share capital € 530.000,00 fully paid
R.E.A. 276961